欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Cell Cycle/DNA Damage-Polo-like Kinase (PLK)-GSK461364
GSK461364

Chemical Structure : GSK461364

CAS No.: 929095-18-1

GSK461364 (GSK461364A, GSK-461364)

货号: PC-45884Not For Human Use, Lab Use Only.

GSK461364 is a potent, selective, and reversible ATP-competitive PLK1 inhibitor with Ki of 2.2 nM.

规格 价格 库存 数量
5 mg ¥880 In stock
10 mg ¥1280 In stock
25 mg ¥2180 In stock
50 mg ¥3680 In stock
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

GSK461364 is a potent, selective, and reversible ATP-competitive PLK1 inhibitor with Ki of 2.2 nM.
GSK461364 displays >390-fold greater selectivity for Plk1 than for Plk2 and Plk3 and 1,000-fold greater selectivity than for a panel of 48 other kinases.
GSK461364 shows antiproliferative activity against >120 tumor cell lines and potently inhibits the proliferation with IC50s of <100 nM.
GSK461364 shows clear antitumor activity in human tumor xenograft models.

物理化学性质&存储条件

分子量 543.6038
分子式 C27H28F3N5O2S
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-Thiophenecarboxamide, 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-

参考文献

1. Olmos D, et al. Clin Cancer Res. 2011 May 15;17(10):3420-30.

2. Gilmartin AG, et al. Cancer Res. 2009 Sep 1;69(17):6969-77.

3. Degenhardt Y, et al. Mol Cancer Ther. 2010 Jul;9(7):2079-89.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: